All News
Filter News
Found 94 articles
-
ILIAS Biologics Inc. demonstrated the therapeutic effect of anti-inflammatory exosomes for ischemia-reperfusion-induced acute kidney injury
6/28/2021
Anti-inflammatory exosomes could have a place in treating acute kidney injury (AKI) caused by ischemia repercussion injury (IRI), according to a study done by ILIAS Biologics, Inc. in collaboration with Yonsei University of Seoul, South Korea.
-
Exo Therapeutics Appoints Nagesh Mahanthappa to Board of Directors and Charles W. Roberts to Scientific Advisory Board
3/30/2021
Exo Therapeutics , Inc., a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets, today announced the appointment of Nagesh Mahanthappa, PhD, to the company’s Board of Directors (BOD) and Charles W. Roberts, MD, PhD, to the company’s Scientific Advisory Board (SAB).
-
ILIAS Biologics announces the 2nd POC study, showing anti-inflammatory effects of ILB202 on preterm birth
2/1/2021
ILIAS Biologics, Inc. announced that its latest research in collaboration with researchers at The University of Texas Medical Brand at Galveston (UTMB) is published in the journal Science Advances(Link: https://advances.sciencemag.org/content/7/4/eabd3865).
-
Launching with hearty Series A rounds, these new companies are ready to run.
-
Exo Therapeutics Launches with $25 Million Series A Financing to Unlock Intractable Drug Targets with Exosites
12/16/2020
Exo Therapeutics , Inc., a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets, today announced the completion of a $25 million Series A financing. Investors in the round included Newpath Partners, Novartis Ventur
-
Codiak BioSciences Reports Third Quarter 2020 Financial Results and Operational Progress
11/19/2020
Codiak BioSciences, Inc. (NASDAQ: CDAK), a clinical-stage company focused on pioneering the development of exosome-based therapeutics, today reported third quarter 2020 financial results and operational progress.
-
BioSpace Global Roundup, Nov. 12
11/12/2020
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines. -
Silicon Valley Startup Exo Secures $40M in Series B+ Funding to Advance Handheld Medical Imaging
8/24/2020
Exo (pronounced “echo”), a pioneering health information and devices company, closed a $40 million Series B+ funding round that will fund research and product development on a revolutionary handheld medical device and cloud-based workflow software platform.
-
ILIAS Biologics Granted Key Patent for Exosome-based Drug Delivery System in the United States
7/7/2020
ILIAS Biologics Inc. (the "Company" or "ILIAS"), a global leader in exosome-based therapeutics, announced today that the Company has been granted a key exosome engineering patent by the United States Patent and Trademark Office (USPTO).
-
BioSpace Movers & Shakers, May 22
5/22/2020
Pharma and life sciences companies bolster their executive leadership teams and boards with these Movers & Shakers. -
Top Ultrasound Industry Talent Joining Exo Imaging
11/5/2019
Medical Imaging Startup makes key additions to commercialization and product teams
-
Flagship Pioneering Unveils Cygnal Therapeutics
10/8/2019
Company is Developing Drugs in the Field of Exoneural Biology to Address Cancer, Inflammatory Disease, and More [08-October-2019] CAMBRIDGE, Mass. , Oct. 8, 2019 /PRNewswire/ -- Flagship Pioneering, a unique life sciences innovation enterprise, today unveiled Cygnal Therapeutics . Founded in 2017 in Flagship Labs, Flagship's innovation foundry, Cygnal is the first co
-
Tyto Care Named to the 2019 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
10/2/2019
CB Insights today named Tyto Care to the inaugural Digital Health 150 ranking, showcasing the 150 most promising private digital health companies in the world.
-
LetsGetChecked Named to the 2019 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
10/2/2019
LetsGetChecked recognized for achievements in home health testing
-
Deep Lens, Inc. Named to the 2019 CB Insights Digital Health 150 – List of Most Innovative Digital Health Startups
10/2/2019
Deep Lens, Inc. recognized for achievements in Best Application of AI
-
OSF Ventures Joins $35M Funding Round for Handheld Ultrasound Device
8/12/2019
OSF Ventures has joined a $35 million funding round to support a start-up that's developing a breakthrough handheld, AI ultrasound device that will allow health care providers to make critical, real-time diagnostic decisions.
-
Exo Imaging Emerges from Stealth Mode with $35M Series B Financing Round to Advance Development of the Exo Ultrasound Platform
8/5/2019
Exo Imaging, Inc., a company pioneering a high-performance ultrasound platform based on patented Piezoelectric Micromachined Ultrasonic Transducers (pMUT) technology and artificial intelligence (AI) for imaging and therapeutic applications, announced a $35M Series B financing round.
-
ExoFest 2019 to Feature Latest Exosome and Extracellular Vesicle Research
6/5/2019
Annual One-Day Event Hosted by System Biosciences and UCSF Features Experts in the Field
-
NeurExo Sciences and Henry Ford Health System Present Preclinical Data on Exosomes at ISEV2019 Annual Meeting
4/26/2019
Exosomes demonstrate ability to enhance anti-tumor effect of platinum-based drugs and to ameliorate peripheral neuropathy
-
NewYork-Presbyterian and Columbia University Irving Medical Center Open New Sports Medicine and Performance Training Facility in Westchester
4/9/2019
NewYork-Presbyterian, in collaboration with physicians from Columbia University Irving Medical Center, has launched a state-of-the-art sports medicine and performance training facility in Westchester County that gives patients and athletes access to some of the nation's top sports medicine doctors, therapists, and elite sports performance coaches–all at a single location.